Drug Approval | December 13, 2022
European Commission approves SPEVIGO for generalized pustular psoriasis flares
EC grants conditional marketing authorization based on the EFFISAYIL trial
EC grants conditional marketing authorization based on the EFFISAYIL trial
They also released the Operational Guidelines for Wellness activities at AB-HWCs
Company to open new headquarters in 2024
Anandiben Patel, Governor, Uttar Pradesh will inaugurate the two-day celebrations
35 million mosquito nets supplied to countries in sub-Saharan Africa through partners
More women centric initiatives being the need of the hour for holistic development
The use of procalcitonin testing for sepsis management is highest in the US
Asia’s premier and USA-patented, ANSSI Wellness for spinal decompression was launched in Pune
With this QIP placement, the Dhanuka group, which took over the company in 2018, is also meeting its mandatory obligation to dilute 15 percent stake in the company by March 2023
Dapagliflozin reduces the risk of sustained eGFR, cardiovascular deaths and hospitalization for heart failure in adults with CKD
Subscribe To Our Newsletter & Stay Updated
